Brian T. Crum - 28 Feb 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, General Counsel & Secr.
Signature
/s/ Brian T. Crum
Issuer symbol
LXRX
Transactions as of
28 Feb 2024
Net transactions value
-$67,082
Form type
4
Filing time
29 Feb 2024, 16:27:54 UTC
Previous filing
12 Feb 2024
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +8,750 +6.5% 143,548 28 Feb 2024 Direct F1
transaction LXRX Common Stock Options Exercise +26,096 +18% 169,644 28 Feb 2024 Direct F1
transaction LXRX Common Stock Options Exercise +33,457 +20% 203,101 28 Feb 2024 Direct F1
transaction LXRX Common Stock Tax liability $67,082 -25,604 -13% $2.62 177,497 28 Feb 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -8,750 -100% 0 28 Feb 2024 Common Stock 8,750 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -26,096 -50% 26,097 28 Feb 2024 Common Stock 26,096 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -33,457 -33% 66,913 28 Feb 2024 Common Stock 33,457 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.